US stock · Healthcare sector · Medical Distribution
Company Logo

Cardinal Health, Inc.

CAHNYSE

76.48

USD
-1.40
(-1.80%)
Market Closed
-18.95P/E
12Forward P/E
-0.95P/E to S&P500
20.048BMarket CAP
2.53%Div Yield
Upcoming Earnings
2 Feb
Shares Short
1/13/23
5.23M
Short % of Float
2.65%
Short % of Shares Outs.
2.00%
% Held by Insiders
0.39%
% Held by Institutions
92.69%
Beta
0.79
PEG Ratio
1.42
52w. high/low
81.57/49.70
Avg. Daily Volume
2.92M
Return %
Stock
S&P 500
1 year
46.94
(6.69)
3 years
41.87
24.00
5 years
1.80
42.28
Scale: |
High
Low
62.25
27.79
39.87
24.87
39.29
29.69
47.06
37.53
44.49
36.91
67.75
41.06
83.40
63.06
91.91
74.76
89.97
62.70
84.88
54.66
75.75
42.17
56.88
41.03
60.69
39.05
62.96
45.85
81.57
48.42
79.11
73.86
Currency: USD
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
Revenue per share
219.93
254.30
278.28
274.53
294.45
311.74
296.46
267.11
308.83
371.70
410.02
437.09
485.11
521.92
556.39
650.05
681.23
Earnings per share
4.89
3.63
3.22
1.79
2.75
3.10
0.98
3.42
3.66
4.36
4.06
0.82
4.54
(12.61)
2.09
(3.34)
(3.96)
FCF per share
2.19
3.17
2.89
5.23
3.16
2.65
4.49
6.67
6.75
7.66
2.51
7.62
7.98
5.41
6.95
9.80
12.39
Dividends per share
0.37
0.48
0.56
0.71
0.79
0.87
1.04
1.22
1.39
1.57
1.82
1.86
1.92
1.94
1.96
2.00
2.01
CAPEX per share
0.91
1.05
1.49
0.71
0.84
0.76
0.57
0.73
0.90
1.42
1.22
1.23
1.09
1.28
1.37
1.39
1.42
Book Value per sh.
18.68
21.63
24.40
14.70
16.78
18.10
17.52
18.77
18.84
20.04
21.48
19.36
21.09
6.11
6.13
(2.54)
(1.99)
Comm.Shares outs.
395
358
358
359
349
345
341
341
332
327
317
313
300
293
292
279
275
Avg. annual P/E ratio
13.9
13.8
10.0
19.0
15.4
13.4
51.4
21.2
23.2
17.8
17.7
69.8
10.6
(4.1)
26.0
(18.6)
(18.9)
P/E to S&P500
0.8
0.6
0.1
0.9
0.9
0.9
3.0
1.2
1.2
0.8
0.7
2.8
0.4
(0.1)
0.9
(0.9)
(1.0)
Avg. annual div. yield
0.5%
1.0%
1.7%
2.1%
1.9%
2.1%
2.1%
1.7%
1.6%
2.0%
2.5%
3.3%
4.0%
3.8%
3.6%
3.2%
3.1%
Revenue (m)
86,852
91,091
99,512
98,503
102,644
107,552
101,093
91,084
102,531
121,546
129,976
136,809
145,534
152,922
162,467
181,364
186,999
Operating margin
1.6%
2.3%
1.9%
1.3%
1.5%
1.7%
1.0%
2.1%
2.1%
2.0%
1.6%
0.1%
1.4%
(2.7)%
0.3%
(0.3)%
(0.5)%
Depreciation (m)
322
381
399
254
313
325
397
459
451
641
717
1,032
1,000
913
783
692
695
Net profit (m)
1,931
1,301
1,152
642
959
1,069
334
1,166
1,215
1,427
1,288
256
1,363
(3,696)
611
(933)
(1,094)
Income tax rate
32.9%
32.5%
31.4%
51.6%
36.4%
37.0%
62.3%
35.3%
38.4%
37.1%
32.7%
213.6%
22.0%
2.1%
(89.5)%
(21.2)%
(55.3)%
Net profit margin
2.2%
1.4%
1.2%
0.7%
0.9%
1.0%
0.3%
1.3%
1.2%
1.2%
1.0%
0.2%
0.9%
(2.4)%
0.4%
(0.5)%
(0.6)%
Working capital (m)
3,085
3,808
4,399
3,381
2,946
3,336
3,180
2,824
4,509
2,255
7,124
1,660
1,638
2,325
3,424
2,385
1,137
Long-term debt (m)
3,457
3,687
3,280
1,896
2,175
2,418
3,686
3,171
5,211
4,952
9,068
8,012
7,579
6,765
5,365
4,735
- -
Equity (m)
7,377
7,748
8,725
5,276
5,849
6,244
5,975
6,401
6,256
6,554
6,808
6,059
6,328
1,789
1,791
(709)
(1,781)
ROIC
13.4%
10.0%
9.5%
7.3%
10.8%
11.2%
3.4%
11.5%
10.1%
10.7%
7.6%
(0.7)%
9.5%
(20.2)%
5.7%
(5.6)%
(11.8)%
Return on capital
10.1%
8.3%
7.5%
6.3%
7.0%
7.4%
3.9%
7.4%
7.0%
7.2%
5.3%
0.2%
5.0%
(8.7)%
1.1%
(1.4)%
(2.1)%
Return on equity
26.2%
16.8%
13.2%
12.2%
16.4%
17.1%
5.6%
18.2%
19.4%
21.8%
18.9%
4.2%
21.5%
(206.6)%
34.1%
131.6%
61.4%
Plowback ratio
92.5%
86.7%
82.6%
60.6%
71.4%
71.9%
(5.7)%
64.4%
62.1%
64.1%
55.2%
(127.0)%
57.7%
115.4%
6.2%
159.9%
150.5%
Div.&Repurch./FCF
375.9%
99.2%
15.6%
23.6%
43.6%
77.5%
44.5%
37.8%
63.6%
46.4%
147.7%
47.4%
49.2%
- -
38.1%
- -
- -
Capital Structure
4 Nov · 2022 | Q1
All numbers in millions
Total liabilities
$ 45,167
Total assets
$ 43,387
Long-term debt
$ - -
Cash and equiv.
$ 3,492
Goodwill
$ 5,675
Retained earnings
$ (301)
Common stock
271
Enterprise Value
$ 16,556
Working Capital
Currency: USD, in millions
2020
2021
2022
Cash & Investments
2,771
3,407
4,717
Receivables
8,264
9,103
10,561
Inventory
13,198
14,594
15,636
Other
1,707
4,580
3,967
Current assets
25,940
31,048
32,935
Acc. Payable
21,374
23,700
27,128
Debt due
10
871
580
Other
2,231
3,053
2,842
Current liabilities
23,615
27,624
30,550
Annual growth rates
(avg. rate of change)
1 year
5 years
10 years
Revenue
11.63%
7.33%
6.97%
Cash flow
34.80%
7.36%
24.36%
Earnings
(252.70)%
(76.99)%
(14.12)%
Dividends
(2.44)%
(0.95)%
5.48%
Book value
(139.59)%
(51.69)%
(22.70)%
Insider Trading
Type
Shares
Date
Snow Ola M
InKind
596
12/01/22
Weitzman Deborah
InKind
380
12/01/22
Mayer Jessica L
InKind
5,185
11/15/22
Brennan Michelle
Purchase
200
11/15/22
Brennan Michelle
Purchase
200
11/14/22
Quarterly Revenue
Currency: USD, in millions
Year
1Q
2Q
3Q
4Q
Total
2021
39,065
41,541
39,275
42,586
162,467
2022
43,968
45,457
44,836
47,103
181,364
2023
49,603
- -
- -
- -
- -
Earnings per share
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2021
(0.87)
2.15
0.41
0.40
2.09
2022
0.97
0.18
(4.99)
0.49
(3.34)
2023
0.41
- -
- -
- -
- -
Quarterly dividends paid
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2021
0.50
0.49
0.49
0.48
1.96
2022
0.53
0.50
0.49
0.48
2.00
2023
0.52
- -
- -
- -
- -
Company Description
Sector:
Healthcare
Industry:
Medical Distribution
CEO:
Mr. Michael Kaufmann
Full-time employees:
46,500
City:
Dublin Ohio
Address:
7000 Cardinal Pl
IPO:
Sep 7, 1994
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Recent News
· 28 Dec, 2022 · The Wall Street Journal
· 19 Dec, 2022 · The Wall Street Journal
· 4 Nov, 2022 · The Wall Street Journal
· 22 Aug, 2022 · The Wall Street Journal
· 15 Aug, 2022 · The Wall Street Journal
· 2 Feb, 2022 · The Wall Street Journal
· 26 Jun, 2021 · The Wall Street Journal